Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 25 /hr

★★★★★

☆☆☆☆☆

Hire Jack H.

United Kingdom

USD 25 /hr

Health economist with extensive experience in systematic reviews, economic modelling and economic evaluations.

Profile Summary

I have over 3 years experience as a Health Economics Consultant, during which time I: - Conducted 20+ systematic reviews of clinical, economic, and epidemiological evidence; - Produced 30+ economic models, including cost-effectiveness models, budget impact models, and cost-of-illness models; - Developed 20+ economic evaluations for submission to government agencies around the world, with a particular focus on the UK and EU; - Gained extensive experience writing, proofreading, and editing a wide range of technical and academic documents, including technical and statistical reports, journal articles and abstracts, and applications to government agencies. I also have a First-Class Honours degree in Mathematics from the University of Birmingham, with a special interest in statistics. Relevant modules include Medical Statistics and Statistical Methods in Finance and Economics.

Subject Matter Expertise

• ★ Systematic Literature Review
• ★ Proofreading & Editing
• ★ Health Economics
• ☆ Technical & Scientific Writing
• ☆ Manuscript & Journal Article Writing
• ☆ Economic Evaluation

Services

• Writing
• Research
• Data & AI

Writing Clinical Trial Documentation, Technical Writing, Copywriting, Newswriting

Research User Research, Meta-Research, Gap Analysis, Gray Literature Search, Systematic Literature Review

Data & AI Statistical Analysis

Work Experience

Health Economist (Associate, Senior Associate, Manager)

FIECON

December 2017 - June 2021

Health Economist (Associate, Senior Associate, Manager)

Fiecon

December 2017 - June 2021

Education

BS Mathematics

The University of Birmingham

September 2014 - July 2017

Mathematics BSc

University of Birmingham

September 2014 - July 2017

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

V. Laskier and E. Bertranou and J. Hansen-Maughan and J. Oddsdottir(2019). PREDICTOR OF A POSITIVE RECOMMENDATION IN NICE ONCOLOGY APPRAISALS . Value in Health. 22. p. S505. Elsevier {BV}

L. Walder and J. Hansen-Maughan and J. Oddsdottir and N. Scheffer-Apecechea(2019). THE UPTAKE AND IMPACT OF THE EQ-5D-5L VALUE SET IN NICE TECHNOLOGY APPRAISALS WITHIN ONCOLOGY . Value in Health. 22. p. S502--S503. Elsevier {BV}

Holly Guy and Lydia Walder and Mark Fisher(2019). Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States . PharmacoEconomics. 37. (3). p. 391--405. Springer Science and Business Media {LLC}